Global Thrombocytopenia (Immune & Chemotherapy-induced) Market: Insights, Trends and Forecast (2019-2023)

Publisher Name :
Date: 06-Sep-2019
No. of pages: 95
Inquire Before Buying

The global immune thrombocytopenia (ITP) market is expected to reach 2.27 billion in 2023, growing at a CAGR of 5.82%, for the duration spanning 2019-2023. The factors such as, rising healthcare expenditures, growing female population, rising prevalence of arthritis, increasing incidences of hepatitis C and new cases of diagnosed cancer would drive the growth of the market. However, market growth would be challenged by the lethargic drug approval process, side effects associated with available thrombocytopenia drugs and the availability of alternative treatment options. A few notable trends include, novel drug development for thrombocytopenia, increasing number of awareness programs against thrombocytopenia, and increasing preferences for biosimilars.

The global thrombocytopenia market would witness considerable growth in coming years, due to the rising prevalence of thrombocytopenia and associated risk factors. The most common type of thrombocytopenia is ITP, which is highly prevalent in patients with rheumatoid arthritis. Whereas, CIT (Chemotherapy-Induced Thrombocytopenia) occurs in patients with cancer, due to the involvement of chemotherapy and radiation treatment. Thrombocytopenia in patients with CLD is growing rapidly with an increase in incidences of HCV infections among them.

The fastest growing regional market is the U.S., owing to the high prevalence of thrombocytopenia in patients with cancer as well as chronic liver diseases. Moreover, rising awareness about the symptoms and causes of thrombocytopenia among people, through various campaigns and the FDA approvals of various novel drugs for the treatment of thrombocytopenia would drive considerable growth in the global thrombocytopenia market.

Scope of the report:


  • The report provides a comprehensive analysis of the global thrombocytopenia (Immune and Chemotherapy-induced) market.

  • The major regional market (the U.S.) has been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Novartis AG, Merck and Co., CSL Limited, Amgen Pharmaceuticals, Horizon Therapeutics and Rigel Pharmaceuticals) are also presented in detail.


Key Target Audience:


  • Thrombocytes Drugs Manufacturers

  • Chemical Suppliers

  • End Users (Hospital, Medical Centers, Clinical Institutes)

  • Healthcare Consulting Firms

  • Investment Banks

  • Government Bodies & Regulating Authorities

Global Thrombocytopenia (Immune & Chemotherapy-induced) Market: Insights, Trends and Forecast (2019-2023)

Table of Contents

1. Overview
1.1 Introduction
1.2 Causes of Thrombocytopenia
1.3 Symptoms of Thrombocytopenia
1.4 Diagnosis of Thrombocytopenia
1.5 Treatment of Thrombocytopenia
1.6 Pathophysiology of Thrombocytopenia

2. Global Thrombocytopenia Market
2.1 Global ITP Market
2.1.1 Global ITP Market Forecast by Value
2.1.2 Global ITP Total Patient Volume Forecast
2.1.3 Global ITP Total Patient Volume Forecast by Region
2.1.4 Global ITP Treated Patient Volume Forecast
2.1.5 Global ITP Treated Patient Volume Forecast by Region
2.2 Global CIT Market
2.2.1 Global CIT Total Patient Volume Forecast
2.2.2 Global CIT Total Patient Volume Forecast by Region
2.2.3 Global CIT Treated Patient Volume Forecast
2.2.4 Global CIT Treated Patient Volume Forecast by Region

3. Regional Thrombocytopenia Market
3.1 The U.S.
3.1.1 The U.S. ITP Total Patient Volume Forecast
3.1.2 The U.S. ITP Treated Patient Volume Forecast
3.1.3 The U.S. Doptelet ITP Treated Patient Volume Forecast
3.1.4 The U.S. CIT Total Patient Volume Forecast
3.1.5 The U.S. CIT Treated Patient Volume Forecast
3.1.6 The U.S. Doptelet CIT Treated Patient Volume Forecast
3.1.7 The U.S. CLD Patient Volume Forecast
3.1.8 The U.S. CLD Patient Volume with Severe Thrombocytopenia Forecast
3.1.9 The U.S. CLD Treated Patient Volume with Severe Thrombocytopenia Forecast
3.2 ROW (Rest of World)
3.2.1 ROW ITP Total Patient Volume Forecast
3.2.2 ROW ITP Treated Patient Volume Forecast
3.2.3 ROW CIT Total Patient Volume Forecast
3.2.4 ROW CIT Treated Patient Volume Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising HealthCare Expenditure
4.1.2 Growing Female Population
4.1.3 Rising Prevalence of Arthritis
4.1.4 Increasing Incidences of Hepatitis C
4.1.5 New Cases of Diagnosed Cancer
4.2 Key Trends & Development
4.2.1 Novel Drug Development for Thrombocytopenia
4.2.2 Increasing Number of Awareness Programs about Thrombocytopenia
4.2.3 Increase in Pharmaceutical R&D Expenditures
4.2.4 Increasing Preference for Biosimilars
4.3 Challenges
4.3.1 Lethargic Drug Approval Process
4.3.2 Side Effects Associated With Available Thrombocytopenia Drugs
4.3.3 Availability of Alternative Treatment Options

5. Competitive Landscape
5.1 Global Market
5.1.1 Key Players – Available Drugs for Chronic Thrombocytopenia
5.1.2 Key Players – R&D Comparison
5.1.3 Key Players - Revenue Comparison
5.1.4 Key Players – Market Cap Comparison

6. Company Profiles
6.1 Novartis AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Merck & Co.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Amgen Inc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 CSL Limited
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Horizon Therapeutics
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
6.6 Rigel Pharmaceuticals
6.6.1 Business Overview
6.6.2 Financial Overview
6.6.3 Business Strategies

List of Tables

Causes of Thrombocytopenia
The U.S. Diagnosed Arthritis Population (2000-2020)
Hepatitis C Population in Major Regions (2018)
Global New Cases of Diagnosed Cancer (2018)
Key Players - Available Drugs for Chronic Thrombocytopenia
Key Players - Revenue Comparison (2018)
Key Players - Market Cap Comparison (2019)

List of Figures

Symptoms of Thrombocytopenia
Diagnosis of Thrombocytopenia
Treatment of Thrombocytopenia
Global ITP Market Forecast by Value (2019-2023)
Global Total ITP Total Patient Volume Forecast (2019-2023)
Global ITP Total Patient Volume Forecast by Region (2023)
Global ITP Treated Patient Volume Forecast (2019-2023)
Global ITP Treated Patient Volume Forecast by Region (2023)
Global CIT Total Patient Volume Forecast (2019-2023)
Global CIT Total Patient Volume Forecast by Region (2018/2023)
Global CIT Treated Patient Volume Forecast (2018-2023)
Global CIT Treated Patient Volume Forecast by Region (2018/2023)
The U.S. ITP Total Patient Volume Forecast (2019-2023)
The U.S. ITP Treated Patient Volume Forecast (2019-2023)
The U.S. Doptelet ITP Treated Patient Volume Forecast (2019-2023)
The U.S. CIT Total Patient Volume Forecast (2018-2023)
The U.S. CIT Treated Patient Volume Forecast (2018-2023)
The U.S. Doptelet CIT Treated Patient Volume Forecast (2021-2026)
The U.S. CLD Patient Volume Forecast (2018-2023)
The U.S. CLD Patient Volume with Severe Thrombocytopenia Forecast (2018-2023)
The U.S. CLD Treated Patient Volume with Severe Thrombocytopenia Forecast (2018-2023)
ROW ITP Total Patient Volume Forecast (2019-2023)
ROW ITP Treated Patient Volume Forecast (2019-2023)
ROW CIT Total Patient Volume Forecast (2018-2023)
ROW CIT Treated Patient Volume Forecast (2018-2023)
Global HealthCare Expenditure Per Capita (2014-2018)
Global Female Population (2014-2018)
Novel Drug Development for Thrombocytopenia (2018)
Awareness Programs about Thrombocytopenia (2018)
Global Pharmaceutical R&D Expenditures (2014-2018)
Drugs Approval Process
Key Players - R&D Comparison (2017-2018)
Novartis AG Net Sales and Net Income (2014-2018)
Novartis AG Net Sales by Segment (2018)
Novartis AG Net Sales by Regions (2018)
Merck & Co. Sales and Net Income (2014-2018)
Merck & Co. Sales by Segment (2018)
Merck & Co. Sales by Regions (2018)
Amgen Inc. Total Revenue and Net Income (2014-2018)
Amgen Inc. Total Revenue by Segment (2018)
Amgen Inc. Total Revenue by Regions (2018)
CSL Limited Total Operating Revenue and Net Profit (2014-2018)
CSL Limited Total Operating Revenue by Segment (2018)
CSL Limited Total Operating Revenue by Regions (2018)
Horizon Therapeutics Net Sales and Net Loss (2014-2018)
Horizon Therapeutics Net Sales by Segment (2018)
Horizon Therapeutics Net Sales by Regions (2018)
Rigel Pharmaceuticals Total Revenue and Net Loss (2014-2018)
Rigel Pharmaceuticals Total Revenue by Divisions (2018)

  • Global Biologics Market: Size, Trends & Forecast (2019-2023 Edition)
    Published: 10-Dec-2019        Price: US 1200 Onwards        Pages: 97
    Scope of the Report The report entitled “Global Biologics Market: Size, Trends & Forecast (2019-2023 Edition)”, provides an in-depth analysis of the global biologics market with detailed analysis of the market in terms of value and segments. The report includes a brief regional analysis of North America, South America, Europe, Asia Pacific and Middle East & Africa with their actual and forecasted market size. Under competit......
  • Global Dalbavancin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 10-Dec-2019        Price: US 3480 Onwards        Pages: 106
    Description Scope of the Report: The worldwide market for Dalbavancin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Dalbavancin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regi......
  • Global Ceftaroline Fosamil Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 10-Dec-2019        Price: US 3480 Onwards        Pages: 104
    Description Scope of the Report: The worldwide market for Ceftaroline Fosamil is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Ceftaroline Fosamil in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on man......
  • Global Epidural Anesthetic Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 10-Dec-2019        Price: US 3480 Onwards        Pages: 103
    Description Scope of the Report: The worldwide market for Epidural Anesthetic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Epidural Anesthetic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market ......
  • Global Pumpkin Seed Oil Supplements Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 10-Dec-2019        Price: US 3480 Onwards        Pages: 103
    Description Scope of the Report: The worldwide market for Pumpkin Seed Oil Supplements is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pumpkin Seed Oil Supplements in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the m......
  • Global Iron Deficiency Anemia Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 10-Dec-2019        Price: US 3480 Onwards        Pages: 104
    Description Scope of the Report: The global Iron Deficiency Anemia Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ig......
  • Global OAB Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 10-Dec-2019        Price: US 3480 Onwards        Pages: 109
    Description Scope of the Report: The global OAB Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any cha......
  • Global CD19 (Antibody) Market Professional Survey Report 2019
    Published: 09-Dec-2019        Price: US 3500 Onwards        Pages: 129
    The global CD19(Antibody) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on CD19(Antibody) volume and value at global level, regional level and company level. From a global perspective, this report represents overall CD19(Antibody) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and......
  • Global Emergency Medicine Market Professional Survey Report 2019
    Published: 09-Dec-2019        Price: US 3500 Onwards        Pages: 129
    The global Emergency Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Emergency Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Emergency Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs